Don Conway is the Director for Health Care Initiatives at The Tuck School. In this position he leads collaborative efforts of the Dartmouth Medical School, and Tuck Business School focused on addressing issues facing the Health Care Industry. Dr.Conway also has teaching responsibilities in the MBA curriculum at Tuck School and in Executive Education programs.

Prior to his appointment, Dr. Conway was Head of Global Health Economics and Research of Outcomes (HERO) for Aventis Pharma.

Prior to joining Aventis Pharma, Dr. Conway was Global Director of Epidemiology and Heath Outcomes Research for Abbott Laboratories.  In 1989, he established the Dept. of Technology Management for the American Medical Association, which was American Medicine's first dedicated venture in Health Technology Assessment. His duties for the AMA also included developing Health Policy and he has represented medicine's interest before US Congress and the FDA.

Dr. Conway has served as chairman of the multinational, industry wide Global Health Policy Group.  He has actively participated in Managed Care Advisory Boards covering both product related and Quality of Care issues and has conducted Quality Improvement studies in managed care, and academic medical center settings (Massachusetts General Hospital). In, 2002 Dr. Conway was voted onto PhRma's Health Outcomes Committee which formulates health policies and practices.

Dr. Conway received his Doctor of Medicine (MD) from Rush Medical College in Chicago, holds an MBA from the Amos Tuck School of Business at Dartmouth College.

Dr. Conway has published American Medical Association (JAMA),and The Annals of Internal Medicine.He is also a member of the executive board of the National Patient Advocate Foundation .